|
US5948786A
(en)
|
1996-04-12 |
1999-09-07 |
Sumitomo Pharmaceuticals Company, Limited |
Piperidinylpyrimidine derivatives
|
|
JP2003528144A
(ja)
|
2000-03-24 |
2003-09-24 |
ファーマジーン ラボラトリーズ リミテッド |
頭痛治療のためのプロスタノイドｅｐ４受容体アンタゴニストの使用およびそのアンタゴニストについてのアッセイ
|
|
HN2001000224A
(es)
|
2000-10-19 |
2002-06-13 |
Pfizer |
Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti - inflamatorios y analgesicos.
|
|
GB0031295D0
(en)
|
2000-12-21 |
2001-01-31 |
Glaxo Group Ltd |
Naphthalene derivatives
|
|
GB0031302D0
(en)
|
2000-12-21 |
2001-01-31 |
Glaxo Group Ltd |
Napthalene derivatives
|
|
GB0103269D0
(en)
|
2001-02-09 |
2001-03-28 |
Glaxo Group Ltd |
Napthalene derivatives
|
|
JP2005532291A
(ja)
|
2002-04-12 |
2005-10-27 |
ファイザー株式会社 |
抗炎症薬および鎮痛薬としてのピラゾール化合物
|
|
AU2003216579A1
(en)
|
2002-04-12 |
2003-10-27 |
Pfizer Inc. |
Imidazole compounds as anti-inflammatory and analgesic agents
|
|
US20040023853A1
(en)
|
2002-05-23 |
2004-02-05 |
Peri Krishna G. |
Antagonistic peptides of prostaglandin E2 receptor subtype EP4
|
|
CN100408570C
(zh)
|
2003-01-29 |
2008-08-06 |
阿斯特兰德英国有限公司 |
Ep4受体拮抗剂
|
|
EP1661897B1
(en)
|
2003-08-26 |
2013-12-04 |
Teijin Pharma Limited |
Pyrrolopyrimidinone derivative
|
|
RS20060143A
(sr)
|
2003-09-03 |
2008-06-05 |
Pfizer Inc., |
Jedinjenja fenil ili piridil amida kao antagonisti prostaglandina e2
|
|
EP1678147B1
(en)
|
2003-09-15 |
2012-08-08 |
Lead Discovery Center GmbH |
Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases
|
|
GB0324269D0
(en)
|
2003-10-16 |
2003-11-19 |
Pharmagene Lab Ltd |
EP4 receptor antagonists
|
|
CN1950334A
(zh)
|
2004-05-04 |
2007-04-18 |
辉瑞有限公司 |
邻位取代的芳基或杂芳基酰胺化合物
|
|
JP4054368B2
(ja)
|
2004-05-04 |
2008-02-27 |
ファイザー株式会社 |
置換メチルアリール又はヘテロアリールアミド化合物
|
|
HN2005000795A
(es)
*
|
2004-10-15 |
2010-08-19 |
Aventis Pharma Inc |
Pirimidinas como antagonistas del receptor de prostaglandina d2
|
|
ATE533766T1
(de)
|
2005-05-19 |
2011-12-15 |
Merck Canada Inc |
Chinolinderivate als ep4-antagonisten
|
|
WO2006128129A2
(en)
|
2005-05-26 |
2006-11-30 |
Synta Pharmaceuticals Corp. |
Method for treating cancer
|
|
AR060403A1
(es)
|
2006-04-12 |
2008-06-11 |
Sanofi Aventis |
Compuestos de amino- pirimidina 2,6- sustituidos -4- monosustituidos como antagonistas del receptor de prostaglandina d2
|
|
CA2648729A1
(en)
|
2006-04-24 |
2007-11-01 |
Merck Frosst Canada Ltd. |
Indole amide derivatives as ep4 receptor antagonists
|
|
US7705035B2
(en)
|
2006-06-12 |
2010-04-27 |
Merck Frosst Canada Ltd. |
Indoline amide derivatives as EP4 receptor ligands
|
|
US20080280891A1
(en)
|
2006-06-27 |
2008-11-13 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
|
WO2008008059A1
(en)
|
2006-07-12 |
2008-01-17 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents ans uses thereof
|
|
BRPI0714409A2
(pt)
|
2006-07-14 |
2013-03-12 |
Novartis Ag |
derivados de pirimidina como inibidores de alk-5
|
|
CA2660133C
(en)
|
2006-08-11 |
2015-10-27 |
Merck Frosst Canada Ltd. |
Thiophenecarboxamide derivatives as ep4 receptor ligands
|
|
WO2008039882A1
(en)
|
2006-09-30 |
2008-04-03 |
Sanofi-Aventis U.S. Llc |
A combination of niacin and a prostaglandin d2 receptor antagonist
|
|
US8158671B2
(en)
|
2007-02-26 |
2012-04-17 |
Merck Canada Inc. |
Indole and indoline cyclopropyl amide derivatives as EP4 receptor antagonists
|
|
JP2010522218A
(ja)
|
2007-03-26 |
2010-07-01 |
メルク フロスト カナダ リミテツド |
Ｅｐ４受容体アンタゴニストとしてのナフタレン及びキノリンスルホニル尿素誘導体
|
|
MX2009010297A
(es)
|
2007-03-26 |
2009-10-12 |
Astellas Pharma Inc |
Derivado de ornitina.
|
|
EP2014657A1
(de)
|
2007-06-21 |
2009-01-14 |
Bayer Schering Pharma Aktiengesellschaft |
Diaminopyrimidine als Modulatoren des EP2-Rezeptors
|
|
US20110028463A1
(en)
|
2007-07-03 |
2011-02-03 |
Astellas Pharma Inc. |
Amide compounds
|
|
CA2702008A1
(en)
|
2007-10-12 |
2009-04-16 |
Ingenium Pharmaceuticals Gmbh |
Inhibitors of protein kinases
|
|
US8598202B2
(en)
|
2008-02-19 |
2013-12-03 |
Janssen Pharmaceutica Nv |
Aryl-hydroxyethylamino-pyrimidines and triazines as modulators of fatty acid amide hydrolase
|
|
SI2565191T1
(sl)
|
2008-05-14 |
2014-12-31 |
Astellas Pharma Inc. |
Derivati 4-(indol-7-ilkarbonilaminometil)cikloheksan karboksilne kisline kot EP4 receptorski antagonisti, uporabni za zdravljenje kronične ledvične odpovedi ali diabetične nefropatije
|
|
US20130225528A1
(en)
|
2008-05-21 |
2013-08-29 |
Ariad Pharmaceuticals, Inc. |
Phosphorus Derivatives as Kinase Inhibitors
|
|
EP2320906B1
(en)
|
2008-08-14 |
2016-02-24 |
Beta Pharma Canada Inc. |
Heterocyclic amide derivatives as ep4 receptor antagonists
|
|
CN102164942B
(zh)
|
2008-09-19 |
2017-02-15 |
生物科技研究有限公司 |
三萜系化合物及其使用的方法
|
|
CN102224154A
(zh)
|
2008-09-25 |
2011-10-19 |
默克弗罗斯特加拿大有限公司 |
作为EP4受体拮抗剂的β-咔啉磺酰脲衍生物
|
|
US8906914B2
(en)
|
2009-08-18 |
2014-12-09 |
Janssen Pharmaceutica Nv |
Ethylene diamine modulators of fatty acid hydrolase
|
|
EP2504008A1
(en)
|
2009-11-23 |
2012-10-03 |
Lexicon Pharmaceuticals, Inc. |
Methods and assays for the treatment of irritable bowel syndrome
|
|
CN103003264B
(zh)
|
2010-05-21 |
2014-08-06 |
切米利亚股份公司 |
嘧啶衍生物
|
|
PH12013500467A1
(en)
|
2010-09-21 |
2013-04-29 |
Eisai R&D Man Co Ltd |
Pharmaceutical composition
|
|
JP5273689B2
(ja)
|
2010-09-29 |
2013-08-28 |
株式会社エヌビィー健康研究所 |
ヒトプロスタグランジンｅ２受容体ｅｐ４に対する抗体
|
|
EA201390717A1
(ru)
|
2010-11-17 |
2013-10-30 |
Новартис Аг |
3-(аминоарил)пиридиновые соединения
|
|
WO2012066065A1
(en)
|
2010-11-17 |
2012-05-24 |
Novartis Ag |
Phenyl-heteroaryl amine compounds and their uses
|
|
CA2820109C
(en)
|
2010-12-10 |
2018-01-09 |
Rottapharm S.P.A. |
Pyridine amide derivatives as ep4 receptor antagonists
|
|
WO2012103071A2
(en)
|
2011-01-25 |
2012-08-02 |
Eisai R&D Management Co., Ltd. |
Compounds and compositions
|
|
CA2830129C
(en)
|
2011-03-24 |
2016-07-19 |
Chemilia Ab |
Novel pyrimidine derivatives
|
|
EP2702043A1
(en)
|
2011-04-29 |
2014-03-05 |
Exelixis, Inc. |
Inhibitors of inducible form of 6-phosphofructose-2-kinase
|
|
US9518044B2
(en)
|
2011-06-20 |
2016-12-13 |
Emory University |
Prostaglandin receptor EP2 antagonists, derivatives, compositions, and uses related thereto
|
|
US9181279B2
(en)
|
2011-07-04 |
2015-11-10 |
Rottapharm Biotech S.R.L. |
Cyclic amine derivatives as EP4 receptor antagonists
|
|
EP2554662A1
(en)
|
2011-08-05 |
2013-02-06 |
M Maria Pia Cosma |
Methods of treatment of retinal degeneration diseases
|
|
WO2013090552A1
(en)
|
2011-12-13 |
2013-06-20 |
Yale University |
Compositions and methods for reducing ctl exhaustion
|
|
IN2014KN02601A
(enExample)
|
2012-04-24 |
2015-05-08 |
Vertex Pharma |
|
|
TWI572597B
(zh)
|
2012-06-29 |
2017-03-01 |
美國禮來大藥廠 |
二甲基－苯甲酸化合物
|
|
AR091429A1
(es)
|
2012-06-29 |
2015-02-04 |
Lilly Co Eli |
Compuestos de fenoxietil piperidina
|
|
EP2711364A1
(en)
|
2012-09-21 |
2014-03-26 |
Chemilia AB |
4-(Indolyl or benzimidazolyl)amino-2-(2-(indol-3-yl)ethyl)aminopyrimidines useful for the treatment of cancer
|
|
CA2888338C
(en)
|
2012-11-27 |
2021-07-20 |
Thomas Helledays Stiftelse For Medicinsk Forskning |
Mth1 inhibitors for treatment of cancer
|
|
UA115576C2
(uk)
|
2012-12-06 |
2017-11-27 |
Байєр Фарма Акцієнгезелльшафт |
Похідні бензимідазолу як антагоністи ер4
|
|
EP2765128A1
(en)
|
2013-02-07 |
2014-08-13 |
Almirall, S.A. |
Substituted benzamides with activity towards EP4 receptors
|
|
TW201443004A
(zh)
|
2013-02-15 |
2014-11-16 |
Lilly Co Eli |
苯氧基乙氧基化合物
|
|
TWI636046B
(zh)
|
2013-05-17 |
2018-09-21 |
美國禮來大藥廠 |
苯氧基乙基二氫－１ｈ－異喹啉化合物
|
|
PT3009426T
(pt)
|
2013-06-12 |
2018-06-08 |
Kaken Pharma Co Ltd |
Derivado de 4-alquinilimidazole e medicamento compreendendo o mesmo como ingrediente ativo
|
|
EA029901B1
(ru)
|
2013-09-04 |
2018-05-31 |
Бристол-Майерс Сквибб Компани |
Соединения для применения в качестве иммуномодуляторов
|
|
CU24362B1
(es)
|
2013-09-06 |
2018-10-04 |
Aurigene Discovery Tech Ltd |
Derivados de 1,2,4-oxadiazol como inmunomoduladores
|
|
WO2015044900A1
(en)
|
2013-09-27 |
2015-04-02 |
Aurigene Discovery Technologies Limited |
Therapeutic immunomodulating compounds
|
|
ES2705342T3
(es)
|
2013-10-17 |
2019-03-22 |
Vertex Pharma |
Co-cristales de (S)-N-metil-8-(1-((2'-metil-[4,5'-bipirimidin]-6-il)amino)propan-2-il)quinolin-4-carboxamida y derivados deuterados de la misma como inhibidores de DNA-PK
|
|
WO2015058031A1
(en)
|
2013-10-17 |
2015-04-23 |
Vertex Pharmaceuticals Incorporated |
Dna-pk inhibitors
|
|
EA028921B1
(ru)
|
2013-12-17 |
2018-01-31 |
Эли Лилли Энд Компани |
Феноксиэтилы
|
|
DK3083554T3
(da)
|
2013-12-17 |
2019-05-13 |
Lilly Co Eli |
Dimethylbenzoesyreforbindelser
|
|
TW201607943A
(zh)
|
2013-12-19 |
2016-03-01 |
拜耳製藥公司 |
作為ｅｐ４配體之新穎苯并咪唑衍生物
|
|
TW201623277A
(zh)
|
2014-03-26 |
2016-07-01 |
安斯泰來製藥股份有限公司 |
醯胺化合物
|
|
US10052332B2
(en)
|
2014-04-29 |
2018-08-21 |
Emory University |
Prostaglandin receptor EP2 antagonists, derivatives, compositions, and uses related thereto
|
|
US20170182003A1
(en)
|
2014-05-23 |
2017-06-29 |
Eisai R&D Management Co., Ltd. |
Combination therapies for the treatment of cancer
|
|
RU2016151390A
(ru)
|
2014-06-04 |
2018-07-17 |
Томас Хелледайс Стифтелсе Фёр Медисинск Форскнинг |
Ингибиторы мтн1 для лечения воспалительных и аутоиммунных заболеваний
|
|
WO2016021742A1
(en)
|
2014-08-07 |
2016-02-11 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compounds as ep4 receptor antagonists
|
|
TWI739666B
(zh)
|
2015-01-09 |
2021-09-11 |
日商小野藥品工業股份有限公司 |
醫藥組成物
|
|
EP3325490B1
(en)
|
2015-07-23 |
2019-12-18 |
Takeda Pharmaceutical Company Limited |
1-substituted 1,2,3,4-tetrahydro-1,7-naphthyridin-8-amine derivatives and their use as ep4 receptor antagonists
|
|
MX390051B
(es)
|
2015-10-16 |
2025-03-20 |
Eisai R&D Man Co Ltd |
Antagonistas de ep4.
|
|
CR20180323A
(es)
|
2015-11-20 |
2018-08-06 |
Idorsia Pharmaceuticals Ltd |
Derivados de indol n-sustituídos como moduladores de los receptores de pge2
|
|
AU2017295720B2
(en)
|
2016-07-13 |
2021-07-22 |
Vertex Pharmaceuticals Incorporated |
Methods, compositions and kits for increasing genome editing efficiency
|
|
US20200069686A1
(en)
|
2017-05-18 |
2020-03-05 |
Idorsia Pharmaceuticals Ltd |
N-substituted indole derivatives
|
|
AR111941A1
(es)
|
2017-05-18 |
2019-09-04 |
Idorsia Pharmaceuticals Ltd |
Derivados de pirimidina como moduladores del receptor de pge2
|
|
EP3625223B1
(en)
|
2017-05-18 |
2021-08-11 |
Idorsia Pharmaceuticals Ltd |
Pyrimidine derivatives
|
|
MX388257B
(es)
|
2017-05-18 |
2025-03-19 |
Idorsia Pharmaceuticals Ltd |
Derivados de pirimidina como moduladores del receptor de pge2.
|